Загрузка...
An analysis of fosaprepitant-induced venous toxicity in patients receiving highly emetogenic chemotherapy
PURPOSE: Fosaprepitant is an antiemetic used for chemotherapy-induced nausea and vomiting. We recently reported increased infusion site adverse events (ISAE) in a cohort of breast cancer patients receiving chemotherapy with doxorubicin and cyclophosphamide (AC). In this current study, we evaluated t...
Сохранить в:
| Опубликовано в: : | Support Care Cancer |
|---|---|
| Главные авторы: | , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4383176/ https://ncbi.nlm.nih.gov/pubmed/24964876 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00520-014-2326-9 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|